Burlington, MA -  RedShift BioAnalytics, Inc. (RedShiftBio) announced its award winning AQS3™pro, based on Microfluidic Modulation Spectroscopy (MMS) technology, is now available in Japan, following the appointment of Primetech as exclusive distributor.  This partnership follows the announcement in May of appointing Topbiox as its distributor in China, and continuing RedShiftBio’s response to the rapid growth [...]

Leading enterprise software will integrate digital innovation efforts at Servier by automating data workflows and enabling R&D collaborators to benefit from scientific data integration and harmonization Basel, Switzerland – Genedata, the leading provider of enterprise software solutions for biopharmaceutical R&D, today announced that leading French biopharmaceutical company Laboratoires Servier has selected Genedata Screener® as part of [...]

Novel platform initially focussed on high-resolution industrial scale processing of therapeutic mRNA Ajdovšcina, Slovenia: BIA Separations, a leading bio-chromatography development and manufacturing company, today announced the introduction of its novel PrimaS™ ligand technology. The proprietary multi-use platform faciliates high-resolution and high speed processing and addresses many underserved but critical separation problems in the context of fast [...]

Newark, CA – Intabio, Inc., a developer of analytical solutions that provide profound efficiency gains across all stages of biopharmaceutical development and manufacturing, today announces commercial availability of the Blaze System. Blaze addresses a critical bottleneck for biopharmaceutical developers by identifying unwanted structural modifications in intact biotherapeutic proteins with blazing speed, enabling scientists to make [...]

Reliable, easy-to-use cryo-EM workflow solution quadruples throughput for pharma labs HILLSBORO, Ore. -- To help pharmaceutical companies obtain faster results in their drug discovery process and reduce the cost of bringing new drugs to market, Thermo Fisher Scientific has released the Thermo Scientific iSPA Workflow, the first commercially available single particle analysis (SPA) workflow solution. As pharmaceutical labs [...]

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN) today announced the appointment of healthcare industry executive Carrie Eglinton Manner to its Board of Directors. Ms. Eglinton Manner brings to the director role over 23 years of leadership experience across multiple disciplines. She currently serves as Senior Vice President, Advanced Diagnostics at Quest Diagnostics (NYSE:DGX), the world’s leading [...]

Designation follows recent announcement on development of first companion diagnostic using the Oncomine Precision Assay on the new Ion Torrent Genexus System CARLSBAD, Calif. -- The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to Thermo Fisher Scientific's Oncomine Precision Assay to identify low-grade glioma (LGG) patients with isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) [...]

Corning’s pre-coated Matrigel matrix-3D plates streamline workflows and deliver a more consistent and convenient solution for high throughput environments Corning Incorporated today announced the launch of Corning® Matrigel® matrix-3D plates, pre-dispensed with Matrigel matrix to provide a more consistent and convenient, ready-to-use cell culture option to support organoid and spheroid culture models. This new 3D tool [...]

Rick Klausner, Bob Nelsen, and Jim Tananbaum team up with Bit Bio to uncover the “operating system of life” and accelerate the company’s drive towards industrial-scale manufacturing of all human cells CAMBRIDGE  — Bit Bio, a Cambridge-based synthetic biology company combining data science and biology to code cells for the wellb eing of humanity, today announces the close [...]

Heerlen, NL Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces that it has reached agreement to acquire Erber Group for an enterprise value of €980m. The value of the transaction represents an EV/EBITDA multiple of about 14x the 2020 EBITDA (fiscal year ending September 2020). The transaction – which excludes [...]